These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 38686454)
41. Genome sequencing of SARS-CoV-2 in a cohort of Egyptian patients revealed mutation hotspots that are related to clinical outcomes. Zekri AN; Mohanad M; Hafez MM; Soliman HK; Hassan ZK; Abouelhoda M; Amer KE; Seadawy MG; Ahmed OS Biochim Biophys Acta Mol Basis Dis; 2021 Aug; 1867(8):166154. PubMed ID: 33932525 [TBL] [Abstract][Full Text] [Related]
43. Identification of high-affinity inhibitors of SARS-CoV-2 main protease: Towards the development of effective COVID-19 therapy. Mohammad T; Shamsi A; Anwar S; Umair M; Hussain A; Rehman MT; AlAjmi MF; Islam A; Hassan MI Virus Res; 2020 Oct; 288():198102. PubMed ID: 32717346 [TBL] [Abstract][Full Text] [Related]
44. Mutational spectra of SARS-CoV-2 orf1ab polyprotein and signature mutations in the United States of America. Banerjee S; Seal S; Dey R; Mondal KK; Bhattacharjee P J Med Virol; 2021 Mar; 93(3):1428-1435. PubMed ID: 32779784 [TBL] [Abstract][Full Text] [Related]
45. Identification of oligopeptides from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) non structural protein 8 (NSP8) and their similarities with type 1 angiotensin II receptor key sites. Achour A Biomed Pharmacother; 2021 Sep; 141():111722. PubMed ID: 34144455 [TBL] [Abstract][Full Text] [Related]
48. Remdesivir MD Simulations Suggest a More Favourable Binding to SARS-CoV-2 RNA Dependent RNA Polymerase Mutant P323L Than Wild-Type. Mohammad A; Al-Mulla F; Wei DQ; Abubaker J Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34206274 [TBL] [Abstract][Full Text] [Related]
49. Potential drug targets of SARS-CoV-2: From genomics to therapeutics. Shamsi A; Mohammad T; Anwar S; Amani S; Khan MS; Husain FM; Rehman MT; Islam A; Hassan MI Int J Biol Macromol; 2021 Apr; 177():1-9. PubMed ID: 33577820 [TBL] [Abstract][Full Text] [Related]
50. Selenoprotein S Interacts with the Replication and Transcription Complex of SARS-CoV-2 by Binding nsp7. Ghelichkhani F; Gonzalez FA; Kapitonova MA; Rozovsky S J Mol Biol; 2023 Apr; 435(8):168008. PubMed ID: 36773692 [TBL] [Abstract][Full Text] [Related]
51. Identification of a membrane-associated element (MAE) in the C-terminal region of SARS-CoV-2 nsp6 that is essential for viral replication. Han Y; Yuan Z; Yi Z J Virol; 2024 May; 98(5):e0034924. PubMed ID: 38639488 [TBL] [Abstract][Full Text] [Related]
52. SARS-CoV-2 and SARS-CoV: Virtual screening of potential inhibitors targeting RNA-dependent RNA polymerase activity (NSP12). Ruan Z; Liu C; Guo Y; He Z; Huang X; Jia X; Yang T J Med Virol; 2021 Jan; 93(1):389-400. PubMed ID: 32579254 [TBL] [Abstract][Full Text] [Related]
53. Identifying Small-Molecule Inhibitors of SARS-CoV-2 RNA-Dependent RNA Polymerase by Establishing a Fluorometric Assay. Bai X; Sun H; Wu S; Li Y; Wang L; Hong B Front Immunol; 2022; 13():844749. PubMed ID: 35464436 [TBL] [Abstract][Full Text] [Related]
55. Bio-Chemoinformatics-Driven Analysis of nsp7 and nsp8 Mutations and Their Effects on Viral Replication Protein Complex Stability. Subong BJJ; Ozawa T Curr Issues Mol Biol; 2024 Mar; 46(3):2598-2619. PubMed ID: 38534781 [TBL] [Abstract][Full Text] [Related]
56. Evaluation on the use of Nanopore sequencing for direct characterization of coronaviruses from respiratory specimens, and a study on emerging missense mutations in partial RdRP gene of SARS-CoV-2. Chan WS; Au CH; Lam HY; Wang CLN; Ho DN; Lam YM; Chu DKW; Poon LLM; Chan TL; Zee JS; Ma ESK; Tang BSF Virol J; 2020 Nov; 17(1):183. PubMed ID: 33225958 [TBL] [Abstract][Full Text] [Related]
57. Mutational landscape and in silico structure models of SARS-CoV-2 spike receptor binding domain reveal key molecular determinants for virus-host interaction. Nelson-Sathi S; Umasankar PK; Sreekumar E; Nair RR; Joseph I; Nori SRC; Philip JS; Prasad R; Navyasree KV; Ramesh S; Pillai H; Ghosh S; Santosh Kumar TR; Pillai MR BMC Mol Cell Biol; 2022 Jan; 23(1):2. PubMed ID: 34991443 [TBL] [Abstract][Full Text] [Related]
58. In silico analysis of RNA-dependent RNA polymerase of the SARS-CoV-2 and therapeutic potential of existing antiviral drugs. Mondal SK; Mukhoty S; Kundu H; Ghosh S; Sen MK; Das S; Brogi S Comput Biol Med; 2021 Aug; 135():104591. PubMed ID: 34216889 [TBL] [Abstract][Full Text] [Related]
59. Impact of Early Pandemic Stage Mutations on Molecular Dynamics of SARS-CoV-2 M Sheik Amamuddy O; Verkhivker GM; Tastan Bishop Ö J Chem Inf Model; 2020 Oct; 60(10):5080-5102. PubMed ID: 32853525 [TBL] [Abstract][Full Text] [Related]
60. Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches. Safavi A; Kefayat A; Mahdevar E; Abiri A; Ghahremani F Vaccine; 2020 Nov; 38(48):7612-7628. PubMed ID: 33082015 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]